British American Tobacco (BAT) is developing a potential vaccine for COVID-19 through its US bio-tech subsidiary, Kentucky Bio Processing (KBP).
The vaccine is now in the pre-clinical testing phase and if it goes well, BAT is hopeful that, with the right partners and support from government agencies, between 1 and 3 million doses of the...
BAT working on potential COVID-19 vaccine through US Bio-Tech subsidiary - TNG